Search Results

BioHorizons Internal Implants are intended for use in the mandible or maxilla as an artificial root structure for single tooth replacement or for fixed bridgework and dental retention.

BioHorizons Internal Implants may be restored immediately with a temporary prosthesis that is not in functional occlusion, or when splinted together for multiple tooth replacement, or when stabilized with an overdenture supported by multiple implants.

BioHorizons Internal Implants are machined titanium, screw-form endosseous dental implants supplied in 3.5mm, 4.0mm, 5.0mm, 6.0mm diameters across lengths of 9mm, 10.5mm, 12mm and 15mm. Implant material is titanium alloy as specified in ASTM F136 Standard Specification for Wrought Titanium-6Aluminum-4Vanadium ELI (Extra Low Interstitial) Alloy (UNS R56401) for Surgical Implant Applications.

The devices are further processed by roughening the surface with tricalcium phosphate blast media, or by applying hydroxylapatite coating conforming to ASTM F1185 Standard Specification for Composition of Ceramic Hydroxylapatite for Surgical Implants, to promote implant fixation. The product is packaged using materials known in the industry to be appropriate for medical device packaging and is provided with a minimum sterility assurance level of 10^-6, validated in compliance to ANSI / AAMI / ISO 11137-1 Sterilization of healthcare products -- Radiation -- Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices.

The BioHorizons Internal Implant System includes a series of implant catalog item numbers with Laser-Lok® technology applied to the implant collar to provide additional treatment options for the dental implant clinician.

This document describes a 510(k) premarket notification for a dental implant system. As such, it does not contain the information requested regarding acceptance criteria and a study proving a device meets those criteria because it is not a submission for a novel device requiring such a study. Instead, it demonstrates substantial equivalence to previously cleared predicate devices.

Therefore, the following information is not present in the provided text:

1. A table of acceptance criteria and the reported device performance
2. Sample size used for the test set and the data provenance
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
4. Adjudication method for the test set
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
7. The type of ground truth used
8. The sample size for the training set
9. How the ground truth for the training set was established

The document's purpose is to show that the BioHorizons Internal Implant System is substantially equivalent to existing legally marketed devices, primarily by demonstrating similar technological characteristics, materials, and intended use as its predicates (BioHorizons Internal Implant System K042429 and BioHorizons Tapered Internal Implant System K071638). The "study" referenced in this type of submission is typically a comparison of features and performance to the predicate device(s) rather than a de novo clinical trial with specific acceptance criteria as you might see for a novel algorithmic diagnostic device.

Ask a specific question about this device